The coverage of the second dose of the measles-containing vaccine: A cross-sectional survey in a rural health district of Cameroon
Guy Stéphane Nloga , Adidja Amani , Florence Kissougle Nkongo , Roger Mathurin Mfoula Angoula , Fabrice Zobel Lekeumo Cheuyem
Global Health Economics and Sustainability ›› 2025, Vol. 3 ›› Issue (4) : 131 -141.
The coverage of the second dose of the measles-containing vaccine: A cross-sectional survey in a rural health district of Cameroon
Measles remains a significant public health challenge in sub-Saharan Africa, including Cameroon, where vaccination coverage (77%) falls below the World Health Organization target of 95%. This study assessed the coverage of the second dose of measles-containing vaccine (MCV2) and identified factors influencing vaccination uptake in Ngog-Mapubi Health District (HD), Cameroon. A community-based cross-sectional survey was conducted in this rural HD in March 2024, involving 140 parents or guardians of children aged 15-23 months. Data were collected using a pre-tested questionnaire, covering sociodemographic characteristics, vaccination status, and barriers to uptake. Determinants of MCV2 vaccination were identified through logistic regression. Data were analyzed using R statistics version 4.4.2. p<0.05 was considered statistically significant. The study revealed a MCV2 vaccination coverage of 46.4% (95% confidence interval [CI]: 38.0-55.0). Among unvaccinated children, 85.3% (95% CI: 75.3-92.4) of caregivers expressed willingness to vaccinate, indicating high acceptance but persistent barriers. Distance to health facilities (43%), lack of information about vaccine availability (37%), and missed opportunities during health visits (25%) were the most cited obstacles. Awareness of MCV2 was high (89%), but knowledge gaps persisted, with 61% of respondents demonstrating poor understanding of vaccination schedules. Multivariate analysis identified the absence of advanced vaccination strategies (e.g., outreach programs) as the strongest predictor of non-vaccination (adjusted odds ratio = 7.15; 95% CI: 3.19-17.2; p<0.001). Despite a high MCV2 acceptance rate, low MCV2 coverage in this rural district underscores the need for improved access through advanced vaccination strategies and targeted community education. Addressing structural and informational barriers is essential to achieving equitable immunization coverage.
Measles-containing vaccine / Second dose of measles-containing vaccine / Vaccination coverage / Rural health / Cameroon / Immunization barriers / Advanced strategy
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
WHO. (2009). Measles Vaccines: WHO Position Paper. Releve Epidemiologique Hebdomadaire, Vol. 84. p349-360. Available from: https://iris.who.int/handle/10665/241405 [Last accessed on 2025 May 30]. |
| [35] |
WHO. (2019). Measles vaccines: WHO position paper, April 2017-recommendations. Vaccine, 37(2):219-222. |
| [36] |
WHO. (2024). Measles. Geneva: WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/measles |
| [37] |
WHO. (2025a). Improving Health Security by Removing Barriers to Vaccination - Progress at the Local Level in the European Region. WHO, Geneva. Available from: https://www.who.int/europe/news/item/30-04-2025-improving-health-security-by-removing-barriers-to-vaccination---progress-at-the-local-level-in-the-european-region [Last accessed on 2025 May 30]. |
| [38] |
WHO. (2025b). Measles. WHO, Regional Office for Africa. Available from: https://www.afro.who.int/health-topics/measles |
| [39] |
WHO. (2025c). Vaccines and Immunization. Geneva: WHO. Available from: https://www.who.int/health-topics/vaccines-and-immunization |
| [40] |
|
| [41] |
|
/
| 〈 |
|
〉 |